In Subarachnoid haemorrhage Nimodip 10mg Infusion is a calcium channel blocker. It works by relaxing the narrowed blood vessels in the brain so that blood can flow more easily. This prevents further brain damage after bleeding around the brain. It is given as an injection and started as soon as possible after bleeding in the brain is confirmed. Your doctor may switch to a tablet form once treatment with Nimodip 10mg Infusion is completed. Follow your doctor's instructions carefully to get the maximum benefit from this medicine.
Nimodip 10mg Infusion may cause excessive drowsiness with alcohol.
Nimodip 10mg Infusion may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Nimodip 10mg Infusion is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Nimodip 10mg Infusion may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Nimodip 10mg Infusion is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Nimodip 10mg Infusion may not be needed in these patients. Please consult your doctor.
There is limited information available on the use of Nimodip 10mg Infusion in patients with liver disease. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: United Biotech Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: New Medicon Pharma Labs Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ridhima Biocare || ₹14.5/tablet (25% cheaper)